GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cronos Group Inc (FRA:7CI) » Definitions » Gross Profit

Cronos Group (FRA:7CI) Gross Profit : €15.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cronos Group Gross Profit?

Cronos Group's gross profit for the three months ended in Sep. 2024 was €3.3 Mil. Cronos Group's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was €15.0 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Cronos Group's gross profit for the three months ended in Sep. 2024 was €3.3 Mil. Cronos Group's Revenue for the three months ended in Sep. 2024 was €30.9 Mil. Therefore, Cronos Group's Gross Margin % for the quarter that ended in Sep. 2024 was 10.54%.

Cronos Group had a gross margin of 10.54% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

During the past 10 years, the highest Gross Margin % of Cronos Group was 359.64%. The lowest was -74.09%. And the median was 15.72%.


Cronos Group Gross Profit Historical Data

The historical data trend for Cronos Group's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cronos Group Gross Profit Chart

Cronos Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.84 -21.24 -15.57 14.57 10.92

Cronos Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.72 1.75 4.12 5.85 3.25

Competitive Comparison of Cronos Group's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Cronos Group's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cronos Group's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cronos Group's Gross Profit distribution charts can be found below:

* The bar in red indicates where Cronos Group's Gross Profit falls into.



Cronos Group Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Cronos Group's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=80 - 69.079
=10.9

Cronos Group's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=30.872 - 27.618
=3.3

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €15.0 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Cronos Group's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=3.3 / 30.872
=10.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cronos Group  (FRA:7CI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cronos Group had a gross margin of 10.54% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Cronos Group Gross Profit Related Terms

Thank you for viewing the detailed overview of Cronos Group's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Cronos Group Business Description

Traded in Other Exchanges
Address
111 Peter Street, Suite 300, Toronto, ON, CAN, M5V 2H1
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Cronos Group Headlines

No Headlines